NOVEL DEUTERATED COMPOUNDS AS INHIBITORS OF THE BCL6 BTB DOMAIN PROTEIN-PROTEIN INTERACTION AND/OR AS BCL6 DEGRADERS

• 收藏
• 分享

专利权人:

Ontario Institute for Cancer Research (OICR)

发明人:

Methvin Isaac,Anh My Chau,Ahmed Mamai

申请号：

US16955998

公开号：

US20200308147A1

申请日:

2018.12.21

申请国别(地区):

US

年份:

2020

代理人:

摘要：

The present application relates to compounds of Formula I (I) or pharmaceutically acceptable salts, solvates and/or prodrugs thereof, to compositions comprising these compounds or pharmaceutically acceptable salts, solvates and/or prodrugs thereof, and various uses in the treatment of diseases, disorders or conditions that are treatable by inhibiting interactions with BCL6 BTB and/or by degrading BCL6, such as cancer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/